FolioLanternBeta
TWSTTwist Bioscience Corp

Adam Laponis

Chief Financial Officer at Twist Bioscience Corp, as of Oct 13, 2026Sold $4.2M of stock in the past 12 months: 28% under a disclosed plan and 72% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
98K
shares held after the latest filing, Twist Bioscience Corp
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
52K
shares sold, past 12 months
15
days with sales
$1.5M
largest single day, Oct 2, 2026
1
company filed for

Share of stake sold at Twist Bioscience Corp is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $173K to cover taxesOctNov 2025: $24K to cover taxesNovDecJan 2026: $120K under a disclosed planJan 2026: $97K to cover taxesJanFeb 2026: $350K under a disclosed planFeb 2026: $97K to cover taxesFebMarApr 2026: $405K under a disclosed planApr 2026: $130K to cover taxesAprMay 2026: $280K under a disclosed planMay 2026: $108K to cover taxesMayJunJul 2026: $226K to cover taxesJulAug 2026: $273K to cover taxesAugSepOct 2026: $1.9M to cover taxes$1.9MOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Twist Bioscience Corp (TWST)Chief Financial OfficerJan 10, 2024Oct 13, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.